Transcription of NEW ZEALAND DATA SHEET - Medsafe
{{id}} {{{paragraph}}}
New ZEALAND Data SHEET APO-PREDNISONE Please refer to Medsafe website ( ) for the most recent datasheet Page 1 of 13 1. PRODUCT NAME APO-PREDNISONE (1mg, , 5mg & 20mg tablets) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Prednisone 1mg, , 5mg or 20mg Excipient(s) with known effect APO-PREDNISONE tablets contains lactose APO-PREDNISONE tablets are gluten free APO-PREDNISONE 20mg tablets contain FD&C Red No. 3 as colourant For the full list of excipients, see section 3. PHARMACEUTICAL FORM APO-PREDNISONE 1mg tablets are round, white, biconvex, in diameter and identified P over 1 on one side.
severity of the disease and the patient’s response rather than by age or body weight. The usual adult prescribing limit is up to 250mg daily. Short Term Therapy: 20mg to 40mg daily with dosage reductions of 2.5mg or 5mg every 2 to 4 days depending on response. Paediatric population
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}